Published in J Lab Clin Med on November 01, 1970
A prealbumin activator of prekallikrein. 3. Appearance of chemotactic activity for human neutrophils by the conversion of human prekallikrein to kallikrein. J Exp Med (1972) 3.93
Immunopathologic studies in relapsing polychondritis. J Clin Invest (1973) 1.98
The autoactivation of factor XII (Hageman factor) induced by low-Mr heparin and dextran sulphate. The effect of the Mr of the activating polyanion. Biochem J (1987) 1.14
Cell-mediated immunity to cartilage proteoglycan in relapsing polychondritis. Clin Exp Immunol (1974) 0.99
Inhibition of the activation of Hageman factor (factor XII) by peripheral blood cells. J Clin Invest (1987) 0.85
Relative contribution of contact and complement activation to inflammatory reactions in arthritic joints. Ann Rheum Dis (1992) 0.77
Activation of factors XII and XI in thrombogenesis. Bull N Y Acad Med (1972) 0.75
OARSI recommendations for the management of hip and knee osteoarthritis, Part II: OARSI evidence-based, expert consensus guidelines. Osteoarthritis Cartilage (2008) 10.99
OARSI recommendations for the management of hip and knee osteoarthritis: part III: Changes in evidence following systematic cumulative update of research published through January 2009. Osteoarthritis Cartilage (2010) 7.52
Guidelines for the medical management of osteoarthritis. Part II. Osteoarthritis of the knee. American College of Rheumatology. Arthritis Rheum (1995) 5.32
RuvAB acts at arrested replication forks. Cell (1998) 5.08
OARSI recommendations for the management of hip and knee osteoarthritis, part I: critical appraisal of existing treatment guidelines and systematic review of current research evidence. Osteoarthritis Cartilage (2007) 4.34
Replication fork pausing and recombination or "gimme a break". Genes Dev (2000) 3.65
Single-stranded plasmid DNA in Bacillus subtilis and Staphylococcus aureus. Proc Natl Acad Sci U S A (1986) 3.31
The conversion of C'IS to C'1 esterase by plasmin and trypsin. J Exp Med (1967) 3.17
Guidelines for the medical management of osteoarthritis. Part I. Osteoarthritis of the hip. American College of Rheumatology. Arthritis Rheum (1995) 3.05
Single base mutation in the type II procollagen gene (COL2A1) as a cause of primary osteoarthritis associated with a mild chondrodysplasia. Proc Natl Acad Sci U S A (1990) 2.79
Patterned delivery of immunoglobulins to surfaces using microfluidic networks. Science (1997) 2.79
Preservation of tissue-fixed immunoglobulins in skin biopsies of patients with lupus erythematosus and bullous diseases--preliminary report. J Invest Dermatol (1972) 2.66
Amnestic syndrome of the medial temporal type identifies prodromal AD: a longitudinal study. Neurology (2007) 2.61
The inhibition of plasmin, plasma kallikrein, plasma permeability factor, and the C'1r subcomponent of the first component of complement by serum C'1 esterase inhibitor. J Exp Med (1969) 2.39
Are single-stranded circles intermediates in plasmid DNA replication? EMBO J (1986) 2.26
Some relationships among hemostasis, fibrinolytic phenomena, immunity, and the inflammatory response. Adv Immunol (1969) 2.25
Spectrum and possible mechanism of carrageenan cytotoxicity. Am J Pathol (1971) 2.17
Inhibition of activated Hageman factor and activated plasma thromboplastin antecedent by purified serum C1 inactivator. J Lab Clin Med (1970) 2.17
Studies on a complex mechanism for the activation of plasminogen by kaolin and by chloroform: the participation of Hageman factor and additional cofactors. J Clin Invest (1969) 2.14
Current concepts of degenerative joint disease (osteoarthritis). Bull Rheum Dis (1967) 2.08
Impaired cell-mediated immunity in patients with classic hemophilia. N Engl J Med (1983) 2.01
Production of epidermal acantholysis in normal human skin in vitro by the IgG fraction from pemphigus serum. J Invest Dermatol (1976) 1.99
Gene transfer in vivo: sustained expression and regulation of genes introduced into the liver by receptor-targeted uptake. Proc Natl Acad Sci U S A (1994) 1.98
When replication forks stop. Mol Microbiol (1994) 1.94
Genetic linkage of a polymorphism in the type II procollagen gene (COL2A1) to primary osteoarthritis associated with mild chondrodysplasia. N Engl J Med (1990) 1.93
Illegitimate recombination occurs between the replication origin of the plasmid pC194 and a progressing replication fork. EMBO J (1986) 1.85
Estrogens and osteoarthritis. Clin Orthop Relat Res (1986) 1.83
Multinutrient supplement containing ephedra and caffeine causes weight loss and improves metabolic risk factors in obese women: a randomized controlled trial. Int J Obes (Lond) (2006) 1.77
RuvABC-dependent double-strand breaks in dnaBts mutants require recA. Mol Microbiol (2000) 1.76
Studies on the purification of antihemophilic factor (factor 8. I. Precipitation of antihemophilic factor by concanavalin A. J Clin Invest (1969) 1.64
The effect of carrageenan on delayed hypersensitivity reactions. J Immunol (1969) 1.63
Tissue activators of plasminogen. Fed Proc (1990) 1.62
Detection of carriers of classic hemophilia using an immunologic assay for antihemophilic factor (factor 8(). J Clin Invest (1971) 1.61
A randomized trial of itraconazole in allergic bronchopulmonary aspergillosis. N Engl J Med (2000) 1.55
Inhibition of the activation of Hageman factor (factor XII) and of platelet aggregation by extracts of Brugia malayi microfilariae. J Lab Clin Med (1991) 1.52
Impairment of lagging strand synthesis triggers the formation of a RuvABC substrate at replication forks. EMBO J (2001) 1.51
Primary pulmonary hypertension in patients with classic hemophilia. Ann Intern Med (1988) 1.51
Some clotting factors in plasma during danazol therapy: free and total protein S, but not C4b-binding protein, are elevated by danazol therapy. J Lab Clin Med (1992) 1.50
Illegitimate recombination at the replication origin of bacteriophage M13. Proc Natl Acad Sci U S A (1986) 1.50
Growth promoting peptides in osteoarthritis: insulin, insulin-like growth factor-1, growth hormone. J Rheumatol (1990) 1.49
Intermolecular recombination during transformation of Bacillus subtilis competent cells by monomeric and dimeric plasmids. Plasmid (1983) 1.45
Sensitivity to ingested metabisulfite: variations in clinical presentation. J Allergy Clin Immunol (1983) 1.43
Lethality of rep recB and rep recC double mutants of Escherichia coli. Mol Microbiol (1995) 1.41
[Involuntary sterilization of mentally handicapped patients]. Wien Klin Wochenschr (1997) 1.39
Use of plasmids from Staphylococcus aureus for cloning of DNA in Bacillus subtilis. Curr Top Microbiol Immunol (1982) 1.39
Clinical comparison of the effectiveness of novel sonic instruments and curettes for periodontal debridement after 2 months. J Clin Periodontol (2001) 1.39
[Diagnosis and course assessment of collagenoses and vasculitides]. Schweiz Med Wochenschr (1994) 1.39
uvrD mutations enhance tandem repeat deletion in the Escherichia coli chromosome via SOS induction of the RecF recombination pathway. Mol Microbiol (1997) 1.39
Anaphylactic reaction to barium enema. Am J Med (1990) 1.38
Defective activation of clotting, fibrinolytic, and permeability-enhancing systems in human Fletcher trait plasma. Circ Res (1974) 1.38
Inhibition of the activation of Hageman factor (factor XII) by aprotinin (Trasylol) J Lab Clin Med (1992) 1.38
Deletions at stalled replication forks occur by two different pathways. EMBO J (1997) 1.37
Preliminary report of familial thymic lymphosarcoma in Holstein calves. Vet Rec (1989) 1.36
Guidelines for the clinical evaluation of hypersensitivity pneumonitis. Report of the Subcommittee on Hypersensitivity Pneumonitis. J Allergy Clin Immunol (1989) 1.35
Micromosaic immunoassays. Anal Chem (2001) 1.35
Hageman factor: alterations in physical properties during activation. Science (1965) 1.34
Safe administration of influenza vaccine to patients with egg allergy. J Pediatr (1998) 1.34
The major portal of entry of koi herpesvirus in Cyprinus carpio is the skin. J Virol (2009) 1.34
Circles: the replication-recombination-chromosome segregation connection. Proc Natl Acad Sci U S A (2001) 1.34
Studies on the purification of antihemophilic factor (factor VIII). II. Separation of partially purified antihemophilic factor by gel filtration of plasma. J Clin Invest (1969) 1.33
Steroid resistance in bronchial asthma. Ann Intern Med (1968) 1.32
Carrageenan and delayed hypersensitivity. II. Activation of Hageman factor by carrageenan and its possible significance. Proc Soc Exp Biol Med (1969) 1.31
Differences in the binding to fibrin of urokinase and tissue plasminogen activator. Thromb Diath Haemorrh (1972) 1.31
Inheritance of fibrin-stabilising-factor deficiency. Lancet (1968) 1.30
Psychogenic purpura: a re-evaluation of the syndrome of autoerythrocyte sensitization. Medicine (Baltimore) (1968) 1.29
Transcription-induced deletions in Escherichia coli plasmids. Mol Microbiol (1995) 1.28
The replication termination signal terB of the Escherichia coli chromosome is a deletion hot spot. EMBO J (1991) 1.28
DNA transcription and repressor binding affect deletion formation in Escherichia coli plasmids. EMBO J (1992) 1.28
The biology and pathology of the initial stages of blood coagulation. Prog Hematol (1966) 1.28
Permeability-increasing activity in hereditary angioneurotic edema plasma. II. Mechanism of formation and partial characterization. J Clin Invest (1969) 1.27
Coincident classic hemophilia and "idiopathic" thrombocytopenic purpura in patients under treatment with concentrates of antihemophilic factor (factor VIII). N Engl J Med (1983) 1.27
Mechanisms of illegitimate recombination. Gene (1993) 1.27
DNA cloning in Bacillus subtilis. III. Efficiency of random-segment cloning and insertional inactivation vectors. Gene (1980) 1.27
Isolation of a dnaE mutation which enhances RecA-independent homologous recombination in the Escherichia coli chromosome. Mol Microbiol (1997) 1.26
Chronic progressive spinobulbar spasticity. A rare form of primary lateral sclerosis. Arch Neurol (1988) 1.26
Experimentally induced degenerative joint lesions following partial meniscectomy in the rabbit. Arthritis Rheum (1973) 1.25
Retracted Copy choice illegitimate DNA recombination. Cell (1988) 1.22
Changes in antihemophilic factor (AHF, factor 8) procoagulant activity and AHF-like antigen in normal pregnancy, and following exercise and pneumoencephalography. J Lab Clin Med (1972) 1.21
Assay and content of tissue thromboplastin in different organs. Thromb Diath Haemorrh (1965) 1.20
Musculoskeletal findings in obese subjects before and after weight loss following bariatric surgery. Int J Obes (Lond) (2006) 1.20
An hypothesis for the development of atopic allergy in man. Clin Allergy (1972) 1.19
The psychogenic purpuras: a review of autoerythrocyte sensitization, autosensitization to DNA, "hysterical" and factitial bleeding, and the religious stigmata. Semin Hematol (1980) 1.19
Bronchospastic responses to aerosolized metabisulfite in asthmatic subjects: potential mechanisms and clinical implications. J Allergy Clin Immunol (1984) 1.17
Comprehensive outpatient care in rheumatoid arthritis. A controlled study. JAMA (1968) 1.17
Appearance of "pemphigus acantholysis factor" in human skin cultured with pemphigus antibody. J Invest Dermatol (1979) 1.16
Elevated antihemophilic factor (AHF, factor VIII) procoagulant activity and AHF-like antigen in alcoholic cirrhosis of the liver. J Lab Clin Med (1974) 1.16
Steroid myopathy in connective tissue disease. Am J Med (1976) 1.15
The risk of osteoarthritis with running and aging: a 5-year longitudinal study. J Rheumatol (1993) 1.15
Concanavalin A-induced release of skin-reactive factor from lymphoid cells. J Immunol (1970) 1.15
Crystal-induced inflammation associated with chronic renal failure treated with periodic hemodialysis. Am J Med (1969) 1.14
Epsilon aminocaproic acid--a dangerous weapon. N Engl J Med (1969) 1.14
Pemphigus antibody interaction with human epidermal cells in culture. J Clin Invest (1978) 1.13
Copy-choice illegitimate DNA recombination revisited. EMBO J (1994) 1.13
Are desmoglein autoantibodies essential for the immunopathogenesis of pemphigus vulgaris, or just "witnesses of disease"? Exp Dermatol (2006) 1.13